×
About 31,052 results

ALLMedicine™ Menopause Center

Research & Reviews  12,791 results

Symptom Clusters Predict Risk of Metabolic-Syndrome and Diabetes in Midlife: The Study ...
https://doi.org/10.1016/j.annepidem.2021.02.011
Annals of Epidemiology; Reeves AN, Elliott MR et. al.

Feb 25th, 2021 - Women's cardio-metabolic risk increases in midlife. Previous work relating menopause symptoms to diabetes/Metabolic Syndrome (MetS) does not consider the adverse impact of multiple concurrent physical and psychological symptoms in midlife. Data ar...

Prevalence of premature ovarian insufficiency and its determinants in Iranian populatio...
https://doi.org/10.1186/s12905-021-01228-1 10.1093/humrep/deg005 10.1007/s00404-005-0029-7 10.1177/2047487314556004 10.4103/2279-042X.132704 10.1093/hsw/hlx010 10.1186/1750-1172-1-9 10.1002/sim.4780111409 10.1080/13697137.2019.1574738 10.1093/aje/kwi324 10.1097/00042192-200211000-00010 10.1097/GME.0000000000000775 10.1016/j.maturitas.2006.11.004 10.2337/dc12-1020 10.1016/S0895-4356(98)00170-X 10.1016/j.maturitas.2013.04.003 10.1007/s00125-017-4346-8 10.1097/01.GME.0000135247.11972.B3 10.1016/j.ijgo.2012.02.014 10.3346/jkms.2005.20.6.1053 10.1097/GME.0000000000000261 10.1111/1471-0528.12828 10.2188/jea.16.161 10.1016/S1047-2797(97)00207-X 10.5455/jrmds.2014215 10.1016/j.maturitas.2004.02.006 10.1093/aje/kws421 10.1093/humrep/16.8.1657 10.1016/j.ogc.2005.12.001 10.1093/aje/153.9.865 10.1016/0021-9681(87)90113-5 10.1007/s10654-018-0367-y 10.1016/j.maturitas.2008.02.009 10.1038/sj.ijo.0802039 10.1097/GME.0000000000000324 10.1530/REP-09-0568 10.1210/jc.2008-2648 10.1210/jcem.86.5.7463 10.1111/j.1365-2265.2009.03614.x 10.1038/srep18858 10.1016/j.tem.2010.12.002 10.1016/j.pathophys.2008.04.004 10.1007/s10815-011-9592-y 10.1186/1477-7827-3-28 10.1210/jc.2006-2274
BMC Women's Health; Rostami Dovom M, Bidhendi-Yarandi R et. al.

Feb 24th, 2021 - Premature ovarian insufficiency (POI) considered as a concerning health issue for women of reproductive age. In this study we aim to estimate the prevalence of POI and assessing the influential factors. Data was obtained from Tehran lipid and gluc...

Perception of menopause among women of Sarawak, Malaysia.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898429
BMC Women's Health; Syed Alwi SAR, Brohi IB et. al.

Feb 23rd, 2021 - Various factors, including menopausal status, educational and social background, culture, and physical and emotional health, may influence women's perceptions of menopause. This study documents the elements influencing attitudes towards menopause ...

Prevalence of pain in women living with HIV aged 45-60: associated factors and impact o...
https://doi.org/10.1080/09540121.2021.1887445
AIDS Care; Sabin CA, Okhai H et. al.

Feb 22nd, 2021 - As the population of women with HIV ages, an increasing proportion are experiencing the menopause, with potential associated pain. Among 844 participants in the Positive Transitions Through the Menopause (PRIME) study (72.3% black African; median ...

see more →

Guidelines  169 results

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
https://pubmed.ncbi.nlm.nih.gov/33198768/
BMC Medicine; Escala-Garcia M

Nov 16th, 2020 - Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mend...

Do Menopause and Aging Affect the Onset and Progression of Rheumatoid Arthritis and Systemic Lupus Erythematosus?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557711/
Cureus Shah L

Oct 11th, 2020 - Rheumatoid arthritis and systemic lupus erythematosus (SLE) are autoimmune diseases that are commonly seen in the female population. Rheumatoid arthritis mainly consists of distal symmetrical deforming polyarthritis. SLE patients have immune compl...

Management of urinary incontinence in postmenopausal women: An EMAS clinical guide.
https://doi.org/10.1016/j.maturitas.2020.09.005
Maturitas Russo E, Caretto M et. al.

Oct 3rd, 2020 - The prevalence of urinary incontinence and of other lower urinary tract symptoms increases after the menopause and affects between 38 % and 55 % of women aged over 60 years. While urinary incontinence has a profound impact on quality of life, few ...

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200366
Maturitas Ramírez I, De la Viuda E et. al.

Jun 5th, 2020 - COVID-19 is associated with a systemic inflammatory response with activation of coagulation in symptomatic patients. The possibility of coagulopathies in peri- and postmenopausal women taking estrogen therapies makes it necessary to consider antit...

Radiofrequency-Based Devices for Female Genito-Urinary Indications: Position Statements...
https://doi.org/10.1016/j.jsxm.2019.12.015
The Journal of Sexual Medicine; Romero-Otero J, Lauterbach R et. al.

Mar 4th, 2020 - Radiofrequency (RF)-based treatment has been introduced as an esthetic alternative treatment for various medical indications without the scientific backup of a satisfactory body of evidence. Furthermore, the United States Food and Drug Administrat...

see more →

Drugs  447 results see all →

Clinicaltrials.gov  15,155 results

Symptom Clusters Predict Risk of Metabolic-Syndrome and Diabetes in Midlife: The Study ...
https://doi.org/10.1016/j.annepidem.2021.02.011
Annals of Epidemiology; Reeves AN, Elliott MR et. al.

Feb 25th, 2021 - Women's cardio-metabolic risk increases in midlife. Previous work relating menopause symptoms to diabetes/Metabolic Syndrome (MetS) does not consider the adverse impact of multiple concurrent physical and psychological symptoms in midlife. Data ar...

Prevalence of premature ovarian insufficiency and its determinants in Iranian populatio...
https://doi.org/10.1186/s12905-021-01228-1 10.1093/humrep/deg005 10.1007/s00404-005-0029-7 10.1177/2047487314556004 10.4103/2279-042X.132704 10.1093/hsw/hlx010 10.1186/1750-1172-1-9 10.1002/sim.4780111409 10.1080/13697137.2019.1574738 10.1093/aje/kwi324 10.1097/00042192-200211000-00010 10.1097/GME.0000000000000775 10.1016/j.maturitas.2006.11.004 10.2337/dc12-1020 10.1016/S0895-4356(98)00170-X 10.1016/j.maturitas.2013.04.003 10.1007/s00125-017-4346-8 10.1097/01.GME.0000135247.11972.B3 10.1016/j.ijgo.2012.02.014 10.3346/jkms.2005.20.6.1053 10.1097/GME.0000000000000261 10.1111/1471-0528.12828 10.2188/jea.16.161 10.1016/S1047-2797(97)00207-X 10.5455/jrmds.2014215 10.1016/j.maturitas.2004.02.006 10.1093/aje/kws421 10.1093/humrep/16.8.1657 10.1016/j.ogc.2005.12.001 10.1093/aje/153.9.865 10.1016/0021-9681(87)90113-5 10.1007/s10654-018-0367-y 10.1016/j.maturitas.2008.02.009 10.1038/sj.ijo.0802039 10.1097/GME.0000000000000324 10.1530/REP-09-0568 10.1210/jc.2008-2648 10.1210/jcem.86.5.7463 10.1111/j.1365-2265.2009.03614.x 10.1038/srep18858 10.1016/j.tem.2010.12.002 10.1016/j.pathophys.2008.04.004 10.1007/s10815-011-9592-y 10.1186/1477-7827-3-28 10.1210/jc.2006-2274
BMC Women's Health; Rostami Dovom M, Bidhendi-Yarandi R et. al.

Feb 24th, 2021 - Premature ovarian insufficiency (POI) considered as a concerning health issue for women of reproductive age. In this study we aim to estimate the prevalence of POI and assessing the influential factors. Data was obtained from Tehran lipid and gluc...

Premarin - estrogens, conjugated tablet, film coated-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b4dbb7c-4e6d-47c9-b940-fef91f1f4a05

Feb 24th, 2021 - PREMARIN is a mixture of estrogens indicated for: Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause (1.1) Treatment of Moderate to Severe Vulvar and Vaginal Atrophy due to Menopause (1.2) Treatment of Hypoestrogenism due to Hypog...

Estradiol - estradiol tablet-Direct Rx
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc186e19-74dd-f415-e053-2995a90a601b

Feb 23rd, 2021 - Estradiol Tablets USP are indicated in the: Treatment of moderate to severe vasomotor symptoms associated with the menopause. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing so...

see more →

News  2,331 results

Menopause Transition and CVD: A Window of Opportunity
https://www.medscape.com/viewarticle/942982

Dec 27th, 2020 - This transcript has been edited for clarity. Hello. This is Dr JoAnn Manson, professor of medicine at Harvard Medical School and Brigham and Women's Hospital. I'd like to talk with you about a recent report in Circulation, an American Heart Associ...

New AHA Scientific Statement on Menopause and CVD Risk
https://www.medscape.com/viewarticle/941848

Dec 1st, 2020 - Changes in hormones, body composition, lipids, and vascular health during the menopause transition can increase a woman's chance of developing cardiovascular disease (CVD) after menopause, the American Heart Association (AHA) said in a scientific ...

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
https://pubmed.ncbi.nlm.nih.gov/33198768/
BMC Medicine; Escala-Garcia M

Nov 16th, 2020 - Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mend...

Local Estrogen Therapy for Vaginal Atrophy Can Start Before or After Age 60
https://www.staging.medscape.com/viewarticle/939558

Oct 21st, 2020 - NEW YORK (Reuters Health) - Treatment with low-dose local estrogen therapy (ET) to improve symptoms of vaginal atrophy may start before or after age 60, according to a post-hoc analysis of a randomized, placebo-controlled trial in the US and Canad...

Local Estrogen Therapy for Vaginal Atrophy Can Start Before or After Age 60
https://www.medscape.com/viewarticle/939558

Oct 21st, 2020 - NEW YORK (Reuters Health) - Treatment with low-dose local estrogen therapy (ET) to improve symptoms of vaginal atrophy may start before or after age 60, according to a post-hoc analysis of a randomized, placebo-controlled trial in the US and Canad...

see more →

Patient Education  159 results see all →